Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 4;1(3):100064.
doi: 10.1016/j.xinn.2020.100064. eCollection 2020 Nov 25.

Changes in Life Expectancy of Respiratory Diseases from Attaining Daily PM2.5 Standard in China: A Nationwide Observational Study

Affiliations

Changes in Life Expectancy of Respiratory Diseases from Attaining Daily PM2.5 Standard in China: A Nationwide Observational Study

Yin Yang et al. Innovation (Camb). .

Abstract

Although exposure to air pollution increases the risk of premature mortality and years of life lost (YLL), the effects of daily air quality improvement to the life expectancy of respiratory diseases remained unclear. We applied a generalized additive model (GAM) to assess the associations between daily PM2.5 exposure and YLL from respiratory diseases in 96 Chinese cities during 2013-2016. We further estimated the avoidable YLL, potential gains in life expectancy, and the attributable fraction by assuming daily PM2.5 concentration decrease to the air quality standards of China and World Health Organization. Regional and national results were generated by random-effects meta-analysis. A total of 861,494 total respiratory diseases and 586,962 chronic obstructive pulmonary disease (COPD) caused death from 96 Chinese cities were recorded during study period. Each 10 μg/m3 increase of PM2.5 in 3-day moving average (lag02) was associated with 0.16 (95% CI: 0.08, 0.24) years increment in life expectancy from total respiratory diseases. The highest effect was observed in Southwest region with 0.42 (95% CI: 0.22, 0.62) years increase in life expectancy. By attaining the WHO's Air Quality Guidelines, we estimated that an average of 782.09 (95% CI: 438.29, 1125.89) YLLs caused by total respiratory death in each city could be avoided, which corresponded to 1.15% (95% CI: 0.67%, 1.64%) of the overall YLLs, and 0.12 (95% CI: 0.07, 0.17) years increment in life expectancy. The results of COPD were generally consistent with total respiratory diseases. Our findings indicate that reduction in daily PM2.5 concentrations might lead to longer life expectancy from respiratory death.

Keywords: China; chronic obstructive pulmonary disease; fine particulates; respiratory diseases; years of life lost.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

None
Graphical abstract
Figure 1
Figure 1
Regression Coefficients of Daily Years of Life Lost or Mortality Count due to Respiratory Diseases Associated with PM2.5 at Different Lag Days during 2013–2016
Figure 2
Figure 2
Locations of the 96 Study Cities in Mainland China The locations of the 96 cities were indicated by small black circle. The seven regions were shown in different colors.

Similar articles

Cited by

References

    1. Guan W.J., Zheng X.Y., Chung K.F., et al. Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action. Lancet. 2016;388:1939–1951. - PubMed
    1. Yang Y., Tang R., Qiu H., et al. Long term exposure to air pollution and mortality in an elderly cohort in Hong Kong. Environ. Int. 2018;117:99–106. - PubMed
    1. Lin H., Liu T., Xiao J., et al. Mortality burden of ambient fine particulate air pollution in six Chinese cities: results from the Pearl River Delta study. Environ. Int. 2016;96:91–97. - PubMed
    1. Collaborators GBDRF Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659–1724. - PMC - PubMed
    1. Wang C., Xu J., Yang L., et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391:1706–1717. - PubMed

LinkOut - more resources